ASHAP salvage therapy for recurrent and refractory Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

被引:0
|
作者
Hanel, M
Hoffknecht, MM
Peters, SO
Fiedler, F
Hanel, A
Kruger, WH
Zeller, W
Braumann, D
Illiger, HJ
Metzner, B
Schubert, JC
Schmitz, N
Weh, HJ
Kroger, N
Zander, AR
机构
[1] KUCHWALDKRANKENHAUS,CLIN INTERNAL MED 3,DEPT HEMATOL,CHEMNITZ,GERMANY
[2] UNIV HAMBURG,HOSP EPPENDORF,BMT CTR,D-20246 HAMBURG,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4559 / 4559
页数:1
相关论文
共 50 条
  • [41] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Schiepers, Christiaan
    Filmont, Jean-Emmanuel
    Czernin, Johannes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S82 - S88
  • [42] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Christiaan Schiepers
    Jean-Emmanuel Filmont
    Johannes Czernin
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S82 - S88
  • [43] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Hoskin, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 : S37 - S41
  • [44] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma
    EJ Dann
    CK Daugherty
    RA Larson
    Bone Marrow Transplantation, 1997, 20 : 369 - 374
  • [45] Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    O'Connor, OA
    Kelly, W
    Wang, ES
    Richon, V
    Moskowitz, C
    Tong, W
    Donnelly, G
    Zelenetz, AD
    Moore, MAS
    Rifkind, RA
    Marks, PA
    BLOOD, 2001, 98 (11) : 611A - 611A
  • [46] Increased occurrence of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) in families with hereditary nonpolyposis colorectal cancer, HNPCC (Lynch syndrome)
    Teruya-Feldstein, J
    Cohen, L
    Ellis, N
    Greene, J
    Offit, K
    MODERN PATHOLOGY, 2001, 14 (01) : 180A - 180A
  • [47] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    Dann, EJ
    Daugherty, CK
    Larson, RA
    BONE MARROW TRANSPLANTATION, 1997, 20 (05) : 369 - 374
  • [48] Increased occurrence of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) in families with hereditary nonpolyposis colorectal cancer, HNPCC (Lynch syndrome)
    Teruya-Feldstein, J
    Cohen, L
    Ellis, N
    Greene, J
    Offit, K
    LABORATORY INVESTIGATION, 2001, 81 (01) : 180A - 180A
  • [49] Image-guided core-needle biopsy (CNB) in the management of patients with non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Chassagne-Clement, C.
    Ranchere, D.
    Thiesse, P.
    Callet-Bauchu, E.
    Bergeron, C.
    Biron, P.
    Ghesquieres, H.
    Sebban, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 250 - 250
  • [50] Anemia associated with non platinum chemotherapy (CT) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL)
    Coiffier, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S331 - S331